Faculty
Financial Disclosure Information
 It is the policy of
AHC to ensure balance, independence, objectivity, and scientific rigor
in all its education activities. Faculty participating
in our programs are expected to disclose any relationships they may have
with commercial companies whose products or services may be mentioned
so that participants may evaluate the objectivity of the presentations. Faculty
 | Isaac Schiff,
MD - PROGRAM CHAIR
Chief, Vincent Ob/Gyn Service, Massachusetts General Hospital, and
Joe Vincent Meigs Professor of Gynecology, Harvard Medical School,
Boston, Mass. Consultant
for Solvay, Merck-Medco, Alliance for Better Bone Health, MediSpecialist.com
(Medical Advisory Board); Editor in Chief for Menopause:
The Journal of the North American Menopause Society; Speakers’
Bureau for Pfizer, Wyeth-Ayerst, Eli Lilly & Company, Solvay,
Novartis, Pharmacia, Procter & Gamble, and Berlex.
| | |  | Sarah L.
Berga, MD
Professor and Director, Division of Reproductive Endocrinology
and Infertility, Department of Obstetrics, Gynecology, and Reproductive
Sciences, and Psychiatry, University of Pittsburgh School of Medicine,
Magee-Womens Hospital, Pittsburgh, Pa. Grants/research
support from NIH - WHI. Consultant for Women First Healthcare
Inc.
| | |  | Lila E. Nachtigall,
MD
Professor of Obstetrics and Gynecology, Department of Obstetrics
and Gynecology, New York University School of Medicine, New York,
N.Y. Research
support from Novagen, Merck; Board of Directors for NAMS; Speakers’
Bureau for Solvay Pharmaceuticals, Eli Lilly & Company, Wyeth-Ayerst,
Berlex, and Pharmacia.
| | |  | Philip M.
Sarrel, MD
Professor of Obstetrics and Gynecology and Psychiatry, Yale
University School of Medicine, New Haven, Conn. Grants/research
support from Eli Lilly & Company; Consultant for Noven Pharmaceuticals;
Speakers’ Bureau for Pharmacia, Pfizer, and Solvay Pharmaceuticals.
|
|
